|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn645437409 |
| 003 |
OCoLC |
| 005 |
20231117033203.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
100630s1990 cauaf ob 001 0 eng d |
| 040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OCLCO
|d OPELS
|d E7B
|d N$T
|d OCLCQ
|d OCLCF
|d UIU
|d YDXCP
|d OCLCQ
|d LEAUB
|d OCLCO
|d OCLCA
|d EYM
|d OCLCO
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780323152457
|q (electronic bk.)
|
| 020 |
|
|
|a 0323152457
|q (electronic bk.)
|
| 020 |
|
|
|z 9780124387454
|
| 020 |
|
|
|z 0124387454
|
| 035 |
|
|
|a (OCoLC)645437409
|
| 042 |
|
|
|a dlr
|
| 050 |
|
4 |
|a RS431.A66
|b U74 1990
|
| 060 |
|
4 |
|a QV 268.5
|b U84 1989
|
| 072 |
|
7 |
|a MED
|x 022090
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.9/25061
|2 22
|
| 245 |
0 |
0 |
|a Use of X-ray crystallography in the design of antiviral agents /
|c edited by W. Graeme Laver, Gillian M. Air.
|
| 260 |
|
|
|a San Diego :
|b Academic Press,
|c �1990.
|
| 300 |
|
|
|a 1 online resource (xxxiv, 360 pages, 20 unnumbered pages of plates) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
| 583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Antiviral agents.
|
| 650 |
|
0 |
|a Viral antibodies.
|
| 650 |
|
0 |
|a Immune complexes.
|
| 650 |
|
0 |
|a X-ray crystallography.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
2 |
|a Antiviral Agents
|0 (DNLM)D000998
|
| 650 |
|
2 |
|a Crystallography
|x methods
|0 (DNLM)D003461Q000379
|
| 650 |
|
2 |
|a Drug Design
|0 (DNLM)D015195
|
| 650 |
|
2 |
|a Antibodies, Viral
|0 (DNLM)D000914
|
| 650 |
|
2 |
|a Antigen-Antibody Complex
|0 (DNLM)D000936
|
| 650 |
|
2 |
|a Crystallography, X-Ray
|0 (DNLM)D018360
|
| 650 |
|
6 |
|a Antiviraux.
|0 (CaQQLa)201-0025468
|
| 650 |
|
6 |
|a Anticorps antiviraux.
|0 (CaQQLa)201-0254791
|
| 650 |
|
6 |
|a Complexes immuns.
|0 (CaQQLa)201-0028046
|
| 650 |
|
6 |
|a Radiocristallographie.
|0 (CaQQLa)201-0062582
|
| 650 |
|
6 |
|a M�edicaments
|x Conception.
|0 (CaQQLa)201-0203461
|
| 650 |
|
7 |
|a MEDICAL
|x Infectious Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a Antiviral agents
|2 fast
|0 (OCoLC)fst00810869
|
| 650 |
|
7 |
|a Drugs
|x Design
|2 fast
|0 (OCoLC)fst00898790
|
| 650 |
|
7 |
|a Immune complexes
|2 fast
|0 (OCoLC)fst00967863
|
| 650 |
|
7 |
|a Viral antibodies
|2 fast
|0 (OCoLC)fst01167596
|
| 650 |
|
7 |
|a X-ray crystallography
|2 fast
|0 (OCoLC)fst01181820
|
| 650 |
|
7 |
|a R�ontgenkristallographie
|2 gnd
|0 (DE-588)4178310-4
|
| 650 |
|
7 |
|a Arzneimittelentwicklung
|2 gnd
|0 (DE-588)4143176-5
|
| 650 |
|
7 |
|a Virostatikum
|2 gnd
|0 (DE-588)4063598-3
|
| 650 |
|
7 |
|a Aufsatzsammlung
|2 gnd
|0 (DE-588)4143413-4
|
| 653 |
0 |
|
|a Antivirals
|a Design
|
| 655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
| 655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
| 655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
| 700 |
1 |
|
|a Laver, William Graeme,
|d 1929-2008.
|
| 700 |
1 |
|
|a Air, Gillian.
|
| 776 |
0 |
8 |
|i Print version:
|t Use of X-ray crystallography in the design of antiviral agents.
|d San Diego : Academic Press, �1990
|z 9780124387454
|w (DLC) 89037194
|w (OCoLC)20219059
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124387454
|z Texto completo
|
